SEC Form 4 · accession 0001162194-17-000143
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Christopher Linthwaite
Officer — President & CEO
Period of report
Sep 20, 2017
Accepted (ET)
Sep 22, 2017 · 9:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2,F1 | $9.05 | Sep 20, 2017 | D | 140,000 | D | — | Aug 9, 2026 | Common Stock | 140,000 | 0 | D |
| Employee Stock Option (Right to Buy)F2,F3 | $5.13 | Sep 20, 2017 | A | 70,000 | A | — | Sep 20, 2027 | Common Stock | 70,000 | 70,000 | D |
Explanation of responses
- F1The Option provided for vesting of 12/48th of the total number of shares subject to the Option on August 1, 2017 and thirty-six equal monthly installments beginning on September 1, 2017.
- F2On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 140,000 shares of FLDM common stock granted to the Reporting Person on August 9, 2016. In exchange, the Reporting Person received a replacement Option, for 70,000 shares, having an exercise price of $5.13 per share.
- F31/12th of the total number of shares underlying the Option will vest on February 20, 2018, and 1/12th of the total number of shares underlying the Option granted will vest every three months thereafter until fully vested, subject to the Reporting Person's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date.